Patent details

Basic Information

Publication number:

EP1140109

PCT Application Number:

PCT/US/1999/029129

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP999630494

PCT Publication Number:

WO/2000/038691

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TRIPHASIC ORAL CONTRACEPTIVE

French Title of Invention:

CONTRACEPTIF ORAL TRIPHASE

German Title of Invention:

TRIPHASISCHES, ORALES KONTRAZEPTIVUM

SPC Number:

Dates

Filing date:

08/12/1999

Grant date:

01/03/2006

EP Publication Date:

01/03/2006

PCT Publication Date:

06/07/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/10/2001

EP B1 Publication Date:

01/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/12/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/12/1999

 

 

Name:

Ortho-McNeil Pharmaceutical Inc.

Address:

U.S. Route No.202, P.O. Box 300, Raritan, NJ 08869-0602, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

01/03/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

UPMALIS David

Address:

United States (US)

2

Name:

RUBIN Arkady

Address:

United States (US)

3

Name:

SHANGOLD Gary

Address:

United States (US)

Priority

Priority Number:

113394 P

Priority Date:

23/12/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/565;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/11/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages